Born in 2009 from the founders' desire to deepen research and studies on the interactions between microbiota, intestine and brain , Kolfarma boasts over 15 years of history at the service of people .
A pioneer in the development of innovative formulations capable of modulating the intestinal microbiota, it is now present on the market with totally natural, safe and effective products for the care of people's well-being and the improvement in the management of complex pathologies , in particular those related to neurological and neuropsychiatric disorders and their comorbidities, with a specific focus on the pediatric area .
“The collaboration with Kolfarma, developed over the years through scientific research and the development of clinical studies, has led to extremely positive results in the management of numerous pathologies and to concrete clinical applicability, with great benefits for the patients treated and considerable interest from the scientific community.”
— Prof. Pasquale Striano, Full Professor at the University of Genoa and Director of the Pediatric Neurology and Muscular Diseases Unit, IRCCS G. Gaslini of Genoa
Kolfarma owns 3 internationally registered patents , 3 brands active on the market — Serplus®, BizetaFlox® and Lalbaay® — with 6 products developed through research and collaboration with important academic scientific institutions and patient associations .
Recent successes include the expansion of product marketing in some important European countries and the launch of the new internationalization strategy, which aims to make Serplus®, BizetaFlox® and Lalbaay® products available to an ever-increasing number of people in Europe and around the world.